Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cardiovascular Diagnosis and Therapy is Scopus-indexed (Q2, CiteScore 3.4), WoS SCIE, DOAJ. Published by AME Publishing Company.
Checked against the index lists dated .
ISSN 2223-3652Verify ISSN ↗2223-3660Verify ISSN ↗
Publisher: AME Publishing Company
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Cardiology and Cardiovascular Medicine | 182 / 409 | 55th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2016–present, best quartile Q2, CiteScore 3.4.
Cardiovascular Diagnosis and Therapy is Q2 in Cardiology and Cardiovascular Medicine (rank 182 of 409), by CiteScore 2025.
Cardiovascular Diagnosis and Therapy is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.4, which places it in quartile Q2 at the 55th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.611, quartile Q2, with an H-index of 54.
Cardiovascular Diagnosis and Therapy is published by AME Publishing Company. Its print ISSN is 2223-3652 and its online ISSN is 2223-3660.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Cardiovascular Diagnosis and Therapy has an h-index of 64 and a 2-year mean of 2.4 citations per paper (OpenAlex). Its Scopus CiteScore is 3.4, quartile Q2. On 2-year citations it ranks #99 of 398 Scopus journals in Cardiology and Cardiovascular Medicine.
Cardiovascular Diagnosis and Therapy published 106 papers in 2025; its busiest recent year was 2020 with 191. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2025–2026), authors are most often from China (38.8%), United States (18.7%) and Japan (6.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (1.6 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.